Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Kyverna Therapeutics, Inc. (KYTX)

NASDAQ

$6.98

$-0.42

(-5.68%)

Pre-Market

Kyverna Therapeutics, Inc. (KYTX) Live Price Chart

Last updated: ⁦2026-09-16 09:45:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Kyverna Therapeutics, Inc. (KYTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.98, with a market capitalisation of $457.64M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.85 to $13.67. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$457.64M
Open	$7.34
Day's High	$35.06
Day's Low	$1.78
Previous Close	$7.40
Volume	1.00M
Average Volume	1.00M
P/E Ratio	--
52-Week High	$13.67
52-Week Low	$3.85
Dividend Yield	--
Earnings Date	--

Kyverna Therapeutics, Inc. (KYTX) Pre-Market Stock Price

Kyverna Therapeutics, Inc. (KYTX) is trading at $7.41 in pre-market trading as of 2026-09-15 23:31:00, up 0.07% ($0.00) from the previous close of $7.40

Pre-market trading shows how investors are pricing KYTX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Kyverna Therapeutics, Inc. (KYTX) 7-Day Stock Price Change

Over the past seven days, Kyverna Therapeutics, Inc. (KYTX) moved from $8.25 to $6.98, representing a decline of 15.42% ($1.27).

The stock traded between $6.87 and $8.38 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 745.24 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

KYTX 52-Week Price Position

Position in Range: 31.9%

52W Low$3.85

52W High$13.67

KYTX is currently trading at $6.98, placing it 31.9% of the way from its 52-week low of $3.85 to its 52-week high of $13.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kyverna Therapeutics, Inc. (KYTX)?

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Kyverna Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	149
Exchange	NASDAQ
Company Website	https://www.kyvernatx.com

How to Buy Kyverna Therapeutics, Inc. (KYTX) Stock on MEXC

Eligible investors can buy real shares of Kyverna Therapeutics, Inc. (KYTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KYTX and Place Your Order

Open the RealStocks trading page and search for KYTX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kyverna Therapeutics, Inc. (KYTX) stock price today?

Kyverna Therapeutics, Inc. (KYTX) is currently trading at $ 6.98, down 5.70% ($0.42) from the previous close of $ 7.40. Intraday prices update in real time during regular trading hours.

2.Is KYTX stock going up or down today?

As of 2026-09-15 23:31:00, KYTX is trading at $ 6.98, down 5.70% ($0.42) from its previous close of $ 7.40. The stock has traded between $ 1.78 and $ 35.06 during today’s regular session. Past price movements do not guarantee future results.

3.What is KYTX pre-market price?

As of 2026-09-15 23:31:00, KYTX is trading at $ 7.41 in pre-market trading, up 0.07% ($0.00) from the previous close of $ 7.40. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KYTX after-hours price?

As of 2026-09-15 23:31:00, KYTX is trading at $ 6.98 in after-hours trading, down 5.68% ($0.42) from the regular-session close of $ 7.40. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KYTX stock trading now?

KYTX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KYTX sit relative to its 52-week high and low?

Over the past 52 weeks, KYTX has traded between a low of $ 3.85 and a high of $ 13.67. At $ 6.98, the stock is positioned 31.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kyverna Therapeutics, Inc. in?

Kyverna Therapeutics, Inc. (KYTX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kyverna Therapeutics, Inc.'s market capitalisation and where is it listed?

Kyverna Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 457.64M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KYTX valued in terms of P/E ratio and EPS?

KYTX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.47. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kyverna Therapeutics, Inc. pay a dividend?

Kyverna Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.